SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andreas Helke who wrote (3276)12/10/1997 9:28:00 PM
From: Oliver & Co  Read Replies (1) of 6136
 
All we have to do is wait. Unfortunatelly, time is on the side of the Pharmaceutical Cos in this field. And we will only see more patients as time goes by.
At the present rate (doules every 4 years). In 20 years there will be 960 million HIV patients worlwide, 32 million US.

======================================================================

"AIDS Vaccine Unlikely Before 2004 at Earliest"
Reuters (12/09/97); Balouki, Eya
ÿÿÿÿ Based on the progress of current trials, a vaccine against
AIDS is not likely to be available before 2004 or 2005, Dr.
Margaret Johnson of the International AIDS Initiative recently
told a news conference.ÿ She explained that scientists are still
unclear on what immune response is capable of blocking the
development of AIDS, and that it takes at least eight years from
the first phase of testing before a vaccine is available for
community use.ÿ Johnson also noted that most current research is
being conducted on the strain of HIV that is found primarily in
Europe and America.ÿ Given that sub-Saharan Africa accounts for
two-thirds of global HIV cases, she added, there is an urgent
need to develop and test potential vaccines against strains of
the virus found in developing nations.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext